Biotech

All Articles

J &amp J falls period 2 dengue applicant in most up-to-date switch coming from vaccinations

.Johnson &amp Johnson's deprioritization of its own contagious ailment pipeline has actually declare...

Relay sheds 10% of personnel after earlier cutbacks in July

.Accuracy medication biotech Relay Therapies is shedding around 10% of its own staff in initiatives ...

Pentixapharm scores $22M IPO to advance radiopharma tests

.Pentixapharm has generated nearly 20 million europeans ($ 22 million) coming from an IPO, along wit...

Lundbeck faucets Charles Waterway for AI-enabled neuro drug breakthrough

.Lundbeck has used Charles Stream Laboratories' expert system abilities to assist the finding of neu...

Big pharma, biotech 'will not essentially be actually cooperative' in AI: S&ampP

.Large Pharma is actually putting in highly in artificial intelligence to reduce advancement timetab...

I &amp I biotech Triveni elevates $115M for preclinical antitoxins

.Triveni Biography has trapped $115 thousand in set B funds to progress preclinical antibody systems...

IGM turns coming from cancer to autoimmune, shaking up C-suite

.IGM Biosciences ended in 2014 laying off workers and also streamlining its cancer cells pipe. Curre...

Shattuck axes CD47 course over weak efficiency data, gives up 40% of personnel and loses Ono deal

.Shattuck Labs has actually hammered another nail right into the coffin of CD47. After finding a "re...

BioMarin goes CAMPing, striking RNA cope with biotech

.BioMarin is actually including kindling to the R&ampD fire, hitting a match with CAMP4 Therapies fo...

Cash- strapped Gritstone begins seek critical choices as cancer vaccine data underwhelm

.Gritstone bio has generated bankers to check out "prospective value-maximizing tactics" after its s...